# AbbVie to invest $380 million to build two API facilities in Illinois

AbbVie announced a $380 million investment to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, expanding domestic production for neuroscience and obesity medicines.

- Type: Expansion
- Announced: 2026-02-23
- Where: Illinois, United States
- Value: $380.0M
- Status: announced
- Products: active pharmaceutical ingredients, neuroscience medicines, obesity medicines
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [AbbVie](https://endata.com/companies/29401.md)

## Sources

- [reuters.com](https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-invest-380-million-expand-us-manufacturing-illinois-2026-02-23/), 2026-02-23: "AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.